Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 27, 2016 (10 years ago)

Norditropin FlexPro Somatropin

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21

Affected NDC 0169-7703-21

Compare with the code on your package — it is the most precise check available.

Drug: Somatropin

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Norditropin
somatropin
NDC 00169-7703
30 mg/3mL Injection, Solution
Subcutaneous
Novo Nordisk Rx
Recalling firm
Novo Nordisk Inc
NDC code
0169-7703-21
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0956-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Somatropin recalls

See all
Class II · Moderate risk

ZOMA-Jet 10 Demonstration Kit

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Terminated Packaging defect Ferring Pharmaceuticals Inc D-0318-2021
Class II · Moderate risk

ZOMA-Jet 5 Demonstration Kit

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Terminated Packaging defect Ferring Pharmaceuticals Inc D-0317-2021
Class II · Moderate risk

Tev-Tropin

Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.

Terminated Chemical / undeclared Ferring Pharmaceuticals Inc NDC 57844-713-46 D-1385-2014
Class III · Low risk

Tev-Tropin

Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A

Terminated Labeling / mix-up Ferring Pharmaceuticals Inc D-240-2013

Other recalls by Novo Nordisk Inc

All 2016 recalls
Class I · High risk

Xultophy 100/3.6

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-2911-90 D-0623-2021
Class II · Moderate risk

ViCTOZA (liraglutide)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-4060-90 D-0622-2021